This Beaten-Down Drug Stock Is Down Over 10% -- Is It Finally a Buy?

Key PointsAbivax's leading candidate looks very promising..

• April 07, 2026 — 03:20 pm EDT Written byProsper Junior BakinyforThe Motley Fool-> Abivax's leading candidate looks very promising
• However, between potential clinical setbacks and the biotech's high market cap, the stock looks risky
• The recent market volatility may have created opportunities to purchase attractive stocks -- those that could perform well over the medium term -- on the dip